Skip to main content

Table 1 Relative luciferase activity of extracts from control and THC treated cells. NIH 3T3 cells co-transfected with MHV 68 ORF 50 plus CMV control (top rows of the table). BCBL-1 cells were co-transfected with the KSHV ORF 50 plus CMV control (bottom rows of the table). Data represent averages from three independent co-transfection experiments.

From: Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro

Treatment of NIH 3T3 cells

MHV 68 ORF 50 promoter (firefly luciferase)

CMV renilla luciferase

DMSO

100% +/- 14%

100% +/- 11%

5 μg/ml THC

13.5% +/- 1.5%

65.8% +/- 9%

Treatment of BCBL-1 cells

KSHV ORF 50 (firefly luciferase)

CMV renilla luciferase

DMSO

100% +/- 14%

100% +/- 3%

5 μg/ml THC

28% +/- 13%

128% +/- 3%